MiR-4668 as a novel potential biomarker for eosinophilic esophagitis

Research output: Contribution to journalArticle

Abstract

Eosinophilic esophagitis (EoE) is a clinico-pathological diagnosis characterized by esophageal dysfunction and eosinophilic infiltration of the esophagus. Demonstration of esophageal eosinophilia (more than 15 eosinophils/hpf) in biopsy specimen obtained by esophagogastroduodenoscopy (EGD) continues to be the gold standard for diagnosis and monitoring of response to therapy. There is a growing necessity for non-invasive biomarkers that can accurately diagnose this condition and assess response to therapy. While microRNAs (miRNA) are being investigated in allergic diseases, including EoE, not many studies have explored the role of salivary miRNAs in EoE. MiR-4668-5p is a particularly interesting candidate, as it is predicted to regulate TGF-beta signaling and has not previously been identified as a target in any allergy disease. We sought to further investigate the role of miR-4668 as a biomarker to characterize and monitor response to treatment with swallowed topical glucocorticoids.
Original languageEnglish (US)
Pages (from-to)1-7
JournalAllergy and Rhinology
Volume11
StatePublished - Aug 2020

Fingerprint Dive into the research topics of 'MiR-4668 as a novel potential biomarker for eosinophilic esophagitis'. Together they form a unique fingerprint.

  • Cite this